Pharmacodynamic-pharmacokinetic Trial, of Slow Release ASA, in the Platelet Functionalism.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The purpose of this study is to evaluate the platelet antiaggregant effect that a chronic treatment with ASA (150 mg) produces,comparing this effect between two formulations of ASA: normal and the one of sustained release, in patients with stable coronary disease.
Epistemonikos ID: 512372a9ceff2bd8188b2e253712dc7f2050c88c
First added on: May 04, 2024